100 related articles for article (PubMed ID: 25869770)
1. Very early mobilization in stroke patients treated with intravenous recombinant tissue plasminogen activator.
Arnold SM; Dinkins M; Mooney LH; Freeman WD; Rawal B; Heckman MG; Davis OA
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1168-73. PubMed ID: 25869770
[TBL] [Abstract][Full Text] [Related]
2. A literature review of cost-effectiveness of intravenous recombinant tissue plasminogen activator for treating acute ischemic stroke.
Joo H; Wang G; George MG
Stroke Vasc Neurol; 2017; 2(2):73-83. PubMed ID: 28736623
[TBL] [Abstract][Full Text] [Related]
3. A Retrospective Analysis of Ischemic Stroke Patients Supports That Very Early Mobilization Within 24 Hours After Intravenous Alteplase Is Safe and Possibly Beneficial.
Yanase L; Clark D; Baraban E; Stuchiner T
J Neurosci Nurs; 2023 Dec; 55(6):188-193. PubMed ID: 37815279
[TBL] [Abstract][Full Text] [Related]
4. Age-specific Cost Effectiveness of Using Intravenous Recombinant Tissue Plasminogen Activator for Treating Acute Ischemic Stroke.
Joo H; Wang G; George MG
Am J Prev Med; 2017 Dec; 53(6S2):S205-S212. PubMed ID: 29153122
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients.
Poupore N; Strat D; Mackey T; Brown K; Snell A; Nathaniel TI
Lipids Health Dis; 2020 May; 19(1):84. PubMed ID: 32375780
[TBL] [Abstract][Full Text] [Related]
6. Evaluation and management of acute ischemic stroke.
Khatri P
Continuum (Minneap Minn); 2014 Apr; 20(2 Cerebrovascular Disease):283-95. PubMed ID: 24699481
[TBL] [Abstract][Full Text] [Related]
7. Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study.
Fagan SC; Waller JL; Nichols FT; Edwards DJ; Pettigrew LC; Clark WM; Hall CE; Switzer JA; Ergul A; Hess DC
Stroke; 2010 Oct; 41(10):2283-7. PubMed ID: 20705929
[TBL] [Abstract][Full Text] [Related]
8. Thrombolytic therapy based on lyophilized platelet-derived nanocarriers for ischemic stroke.
Migliavacca M; Correa-Paz C; Pérez-Mato M; Bielawski PB; Zhang I; Marie P; Hervella P; Rubio M; Maysinger D; Vivien D; Del Pino P; Pelaz B; Polo E; Campos F
J Nanobiotechnology; 2024 Jan; 22(1):10. PubMed ID: 38166940
[TBL] [Abstract][Full Text] [Related]
9. Correlations of 2 Novel Inflammation Indexes With the Risk for Early Neurological Deterioration in Acute Ischemic Stroke Patients After Intravenous Thrombolytic Therapy.
Wang N; Wang L; Zhang M; Deng B; Wu T
Neurologist; 2024 May; 29(3):146-151. PubMed ID: 38323983
[TBL] [Abstract][Full Text] [Related]
10. Telephone consultations for tissue plasminogen activator administration in acute stroke.
Sattin JA
Continuum (Minneap Minn); 2014 Apr; 20(2 Cerebrovascular Disease):429-35. PubMed ID: 24699491
[TBL] [Abstract][Full Text] [Related]
11. rtPA-loaded fucoidan polymer microbubbles for the targeted treatment of stroke.
Fournier L; Abioui-Mourgues M; Chabouh G; Aid R; Taille T; Couture O; Vivien D; Orset C; Chauvierre C
Biomaterials; 2023 Dec; 303():122385. PubMed ID: 37952499
[TBL] [Abstract][Full Text] [Related]
12. Severe Epistaxis after Tissue Plasminogen Activator administration for Acute Ischemic Stroke in SARS-COV-2 Infection.
Khandelwal P; Martínez-Pías E; Bach I; Prakash T; Hillen ME; Martínez-Galdámez M; Arenillas JF
Brain Circ; 2021; 7(2):135-138. PubMed ID: 34189359
[TBL] [Abstract][Full Text] [Related]
13. Levofloxacin-associated transient mixed sensorimotor lacunar syndrome.
Michelassi F; Bloom J; Su MK; Naqvi IA
BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36549757
[TBL] [Abstract][Full Text] [Related]
14. Does evidence really matter? Professionals' opinions on the practice of early mobilization after stroke.
Sjöholm A; Skarin M; Linden T; Bernhardt J
J Multidiscip Healthc; 2011; 4():367-76. PubMed ID: 22096341
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial.
AVERT Trial Collaboration group
Lancet; 2015 Jul; 386(9988):46-55. PubMed ID: 25892679
[TBL] [Abstract][Full Text] [Related]
16. Extra Physiotherapy in Critical Care (EPICC) Trial Protocol: a randomised controlled trial of intensive versus standard physical rehabilitation therapy in the critically ill.
Thomas K; Wright SE; Watson G; Baker C; Stafford V; Wade C; Chadwick TJ; Mansfield L; Wilkinson J; Shen J; Deverill M; Bonner S; Hugill K; Howard P; Henderson A; Roy A; Furneval J; Baudouin SV
BMJ Open; 2015 May; 5(5):e008035. PubMed ID: 26009576
[TBL] [Abstract][Full Text] [Related]
17. Ambulatory extracorporeal membrane oxygenation as a bridge to lung transplantation: walking while waiting.
Lehr CJ; Zaas DW; Cheifetz IM; Turner DA
Chest; 2015 May; 147(5):1213-1218. PubMed ID: 25940249
[TBL] [Abstract][Full Text] [Related]
18. Patient and family perceptions of physical therapy in the medical intensive care unit.
Sottile PD; Nordon-Craft A; Malone D; Schenkman M; Moss M
J Crit Care; 2015 Oct; 30(5):891-5. PubMed ID: 26038155
[TBL] [Abstract][Full Text] [Related]
19. ABCDE, but in that order? A cross-sectional survey of Michigan intensive care unit sedation, delirium, and early mobility practices.
Miller MA; Govindan S; Watson SR; Hyzy RC; Iwashyna TJ
Ann Am Thorac Soc; 2015 Jul; 12(7):1066-71. PubMed ID: 25970737
[TBL] [Abstract][Full Text] [Related]
20. Physical Therapist Practice in the Intensive Care Unit: Results of a National Survey.
Malone D; Ridgeway K; Nordon-Craft A; Moss P; Schenkman M; Moss M
Phys Ther; 2015 Oct; 95(10):1335-44. PubMed ID: 26045604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
